The MarketWatch News Department was not involved in the creation of this content. Neuroendocrine Carcinoma Market Poised for Significant Growth During the Forecast Period (2026-2036) Driven by Rising ...
Good morning, everybody. My name is Kyahn Williamson, SVP of Investor Relations and Corporate Communications at Telix. And we're very pleased to welcome you today to our investor call and webcast to ...
AngioDynamics has reshaped its portfolio into a two‑segment model and concentrated on a higher‑growth Med Tech segment; management said Med Tech grew nearly 20% in the first six months, margins and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results